Tumor Markers in Colorectal Carcinoma An Evaluation of Carcinoembryonic Antigen, Tissue Polypeptide Antigen, Placental Alkaline Phosphatase and Pseudouridine

T. Rasmuson DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

G. R. Björk DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

L. Damber DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

S. E. Holm DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

L. Jacobsson DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

A. Jeppsson DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

T. Stigbrand DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

G. Westman DEPARTMENTS OF ONCOLOGY AND MICROBIOLOGY, THE ONCOLOGIC CENTER, S-90187, UMEå, SWEDEN; DEPARTMENTS OF BACTERIOLOGY, CLINICAL CHEMISTRY AND PHYSIOLOGICAL CHEMISTRY, UNIVERSITY OF UMEå, S-90187, UMEå, SWEDEN

show all

Abstract

The biologic markers carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), placental alkaline phosphatase (PLAP) and pseudouridine were analysed in 37 patients with colorectal carcinoma. CEA, TPA and PLAP were derived from the serum and pseudouridine from the urine. The incidence of all four markers increased with advancing stages of the disease. Patients with distant metastases had elevated levels of CEA, TPA, PLAP and pseudouridine in 85, 27, 18 and 33 per cent of the total cases, respectively. When survival was compared, patients with 2 to 4 elevated markers had shorter survival than those with none or only one elevated marker.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Tumor Markers in Colorectal Carcinoma An Evaluation of Carcinoembryonic Antigen, Tissue Polypeptide Antigen, Placental Alkaline Phosphatase and Pseudouridine

Information for

Open access

Opportunities

Help and information

Tumor Markers in Colorectal Carcinoma An Evaluation of Carcinoembryonic Antigen, Tissue Polypeptide Antigen, Placental Alkaline Phosphatase and Pseudouridine

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature